VRCA - Verrica Pharmaceuticals Inc.

5.31
0.110   2.072%

Share volume: 71,433
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%
$5.20
0.11
0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-13-2024 08-14-2024 11-04-2024 03-11-2025 05-13-2025 08-12-2025 11-14-2025
Total revenue 3.826 M 5.177 M -1.781 M 344.000 K 3.439 M 12.702 M 14.344 M
Cost of revenue 1.138 M 360.000 K 351.000 K 596.000 K 423.000 K 340.000 K 754.000 K
Gross profit 2.688 M 4.817 M -2.132 M -252.000 K 3.016 M 12.362 M 13.590 M
    79.20% -144.26% 88.18% 1,296.83% 309.88% 9.93%  
Operating expenses 21.287 M 19.841 M 18.488 M 11.046 M 11.132 M 10.698 M 11.608 M
Selling general and admin 16.339 M 16.522 M 16.083 M 9.878 M 8.848 M 8.852 M 9.403 M
Research and development 4.948 M 3.319 M 2.405 M 1.168 M 2.284 M 1.846 M 2.205 M
Total expenses 22.425 M 20.023 M 18.572 M 11.158 M 11.146 M 10.852 M 11.963 M
    -10.71% -7.25% -39.92% -0.11% -2.64% 10.24%  
Operating income -18.599 M -15.206 M -20.704 M -11.410 M -8.130 M 1.510 M 1.627 M
Ebit -18.599 M -15.211 M -20.705 M -14.041 M -7.876 M 2.107 M 1.661 M
Pretax income -20.331 M -17.186 M -22.860 M -16.185 M -9.742 M 204.000 K -274.000 K
    -15.47% 33.02% -29.20% -39.81% -102.09% -234.31%  
Income tax 0.000 0.000 0.000 0.000 0.000 0.000 0.000
Net income basic -20.331 M 0.000 0.000 0.000 0.000 0.000 0.000
    100.00%            
Net income -20.331 M -17.186 M -22.860 M -16.202 M -9.742 M 204.000 K -274.000 K
    15.47% -33.02% 29.13% 39.87% 102.09% -234.31%